Pictet Asset Management Holding SA »

Allogene Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $29k 11k 2.80
2024-03-31 $47k 11k 4.47

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Allogene Therapeutics

FMR
Tpg Gp A
BlackRock
Vanguard Group
State Street Corporation
Capital World Investors
Lynx1 Capital Management
Citadel Advisors
PRIMECAP Management Company
T. Rowe Price Associates
Woodline Partners
Jpmorgan Chase & Co
Dimensional Fund Advisors
Geode Capital Management
Wildcat Capital Management

View all funds holding Allogene Therapeutics